Kazia Therapeutics Limited ADR [KZIA] stock is trading at $1.18, up 39.63%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The KZIA shares have gain 38.59% over the last week, with a monthly amount drifted -15.71%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Kazia Therapeutics Limited ADR [NASDAQ: KZIA] stock has seen the most recent analyst activity on February 06, 2025, when Maxim Group initiated its Buy rating and assigned the stock a price target of $3. Previously, Maxim Group started tracking the stock with Buy rating on October 14, 2021, and set its price target to $18. On January 05, 2021, H.C. Wainwright initiated with a Buy rating and assigned a price target of $17 on the stock.
Kazia Therapeutics Limited ADR [KZIA] stock has fluctuated between $0.76 and $15.80 over the past year. Kazia Therapeutics Limited ADR [NASDAQ: KZIA] shares were valued at $1.18 at the most recent close of the market.
Analyzing the KZIA fundamentals
Gross Profit Margin for this corporation currently stands at 1.0%, Pretax Profit Margin comes in at -11.72%, and Net Profit Margin reading is -11.6%. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.8400 points at the first support level, and at 0.5000 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4800, and for the 2nd resistance point, it is at 1.7800.
Ratios To Look Out For
For context, Kazia Therapeutics Limited ADR’s Current Ratio is 0.24. In addition, the Quick Ratio stands at 0.24 and the Cash Ratio stands at 0.06. Considering the valuation of this stock, the price to sales ratio is 2.59.
